ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Calcineurin"

  • 2019 American Transplant Congress

    Nephrotoxicity Caused by Calcineurin Inhibitors is Meditated by BAX, NOL3 and XIAP Apoptotic Genes Dysregulation

    G. Queipo1, M. Fonsecha-Sanchez1, J. Sanchez1, L. Garcia1, M. Carmona2, E. Villanueva1, G. Melendez1, L. Morales-Buenrostro3, M. Alamilla1

    1Hospital General de Mexico-Eduardo Liceaga Facultad de Medicina UNAM, Mexico City, Mexico, 2Facultad de Medicina UNAM, Mexico City, Mexico, 3Instituto Nacional de Ciencias Médicas Salvador Zubirán, Mexico City, Mexico

    *Purpose: Calcineurin inhibitors (CNI) remain the most effective and widely used immunosuppressive agents in kidney transplantation. Nephrotoxicity is a major secondary effect, and renal biopsy…
  • 2019 American Transplant Congress

    How and Why Dyrk1a is Required for Optimal Foxp3+ Treg Functions

    W. W. Hancock, N. Zhou, R. Han, L. Wang

    Children's Hospital of Philadelphia, Philadelphia, PA

    *Purpose: TCR-induced calcineurin phosphatase activation and subsequent Nfat dephosphorylation, leading to Nfat translocation to the nucleus, is a key event in conventional T cell activation.…
  • 2019 American Transplant Congress

    Cardioprotective Effects of Pre-Operative Cyclosporine in Patients Undergoing Heart Transplantation

    Y. Hirase, M. Harris, M. Watson, H. Lee, C. Patel

    Duke University Hospital, Durham, NC

    *Purpose: The purpose of this study is to determine if pre-operative cyclosporine (Cya) decreases the rate of primary graft dysfunction (PGD) in patients undergoing orthotopic…
  • 2019 American Transplant Congress

    Mitochondrial Dysfunction and Metabolic Reprogramming: Critical Features of Cyclosporine A Nephrotoxicity

    A. A. Zmijewska, G. Benavides, V. Darley-Usmar, J. W. Zmijewski, R. B. Mannon

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Calcineurin inhibitors (CNIs) are potent immunosuppressants but over time contribute to allograft fibrosis. Clinical efforts to minimize or avoid CNI have not been uniformly…
  • 2019 American Transplant Congress

    Calcineurin Inhibitors and Long-Term Outcomes of Kidney Transplantation from Thai Transplant Registry

    S. Udomkarnjananun, N. Townamchai, Y. Avihingsanon, K. Praditpornsilpa

    Chulalongkorn University, Bangkok, Thailand

    *Purpose: Calcineurin inhibitors (CNIs) have became the primary immunosuppressive medications (IS) for kidney transplantation (KT) in the current era. However, the long-term outcomes of KT…
  • 2019 American Transplant Congress

    Renal Failure as a Complication of Vascularized Composite Allotransplantation

    R. N. Barth1, J. T. Shores2, G. Brandacher2, M. H. Levine3, A. Weissenbacher4, A. J. Nam1, N. Shockcor1, E. D. Rodriguez5, S. Schneeberger4, W. Lee2, S. T. Bartlett1, L. Levin3

    1University of Maryland School of Medicine, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3University of Pennsylvania School of Medicine, Philadelphia, PA, 4Medical University Innsbruck, Innsbruck, Austria, 5New York University School of Medicine, New York, NY

    *Purpose: Vascularized composite allotransplantation (VCA) has demonstrated impressive outcomes in areas of extremity (UETx), face (FTx), genitourinary, and abdominal wall transplantation with up to twenty…
  • 2019 American Transplant Congress

    The Impact of Early Subtherapeutic Tacrolimus Troughs with Alemtuzumab Induction

    L. Bowman1, E. Yanqui1, C. Truong1, R. Baliga2, A. Brueckner1

    1Tampa General Hospital, Tampa, FL, 2Florida Kidney Physicians, Tampa, FL

    *Purpose: Prior studies in kidney transplant recipients (KTR) have demonstrated that lower tacrolimus (TAC) exposure during the first week is associated with an increased incidence…
  • 2019 American Transplant Congress

    Long Term Renal Function Following Islet Transplantation in the Clinical Islet Transplantation Consortium

    L. G. Hunsicker1, T. L. Eggerman2, M. R. Rickels3, t. Clinical Islet Transplantation (CIT) Consortium4

    1Internal Medicine, U. Iowa, Iowa City, IA, 2NIDDK/NIH, Bethesda, MD, 3Internal Medicine, U. Pennsylvania, Philadelphia, PA, 4Internal Medicine, University of Iowa, Iowa City, IA

    *Purpose: Islet transplantation (IsletTp) is safe and effective treatment of Type 1 diabetes complicated by severe hypoglycemia (Diabetes Care 2016, 39:1230). But the requirement for…
  • 2019 American Transplant Congress

    Alterations in Cerebral Blood Flow before and after Kidney Transplantation

    A. Gupta1, I. Choi2, R. Lepping3, P. Adany4, A. Jurgensen1, J. Klein1, D. Cibrik1, J. Burns5, W. Brooks2, P. Lee2

    1Division of Nephrology, The Kidney Institute, University of Kansas Medical Center, Kansas City, KS, 2Hoglund Brain Imaging Center, Department of Molecular & Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, 3Hoglund Brain Imaging Center, Alzheimer’s Disease Center,, University of Kansas Medical Center, Kansas City, KS, 4Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, KS, 5Alzheimer’s Disease Center, Department of Neurology, University of Kansas Medical Center, Kansas City, KS

    *Purpose: End stage renal disease (ESRD) is associated with alterations in cerebral blood flow (CBF) likely secondary to disrupted cerebral autoregulation. In this study we…
  • 2019 American Transplant Congress

    Dual Treatment of CD40 Silencing or Mesenchymal Stem Cells Infusion with Sub-Therapeutic Doses of Cyclosporine Effectively Prevents Acute Rejection in an Allogenic Model of Renal Transplantation

    J. Guiteras1, L. De Ramon1, N. Bolaños1, M. Franquesa2, M. Gomà3, J. Cruzado4, N. Lloberas1, J. Grinyó4, J. Torras4

    1IDIBELL, Hospitalet de Llobregat, Spain, 2IGTP, Badalona, Spain, 3Bellvitge Hospital, Hospitalet de Llobregat, Spain, 4Bellvitge Hospital / IDIBELL, Hospitalet de Llobregat, Spain

    *Purpose: This study was designed to investigate the combination of CD40 silencing or MSC infusion with suboptimal doses of Cyclosporine in this renal allograft model.*Methods:…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences